Frédéric Pouliot
0000-0002-6651-1079
Publication & Citation Trends
Publications
387 total
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study PDF
Cited by 361
OpenAlex
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY) PDF
Cited by 356
OpenAlex
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma PDF
Cited by 281
OpenAlex
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
Cited by 732
OpenAlex
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma PDF
Cited by 3,336
OpenAlex
Research Topics
Prostate Cancer Treatment and Research
(146)
Renal cell carcinoma treatment
(138)
Renal and related cancers
(66)
Prostate Cancer Diagnosis and Treatment
(64)
Bladder and Urothelial Cancer Treatments
(54)
Affiliations
Dalhousie University
University of California, Los Angeles
Winston-Salem State University
GTx (United States)
Queen Elizabeth II Health Sciences Centre